MAGE-3 (168-176)

MAGE-3 (168-176) is a synthetic peptide fragment derived from the melanoma-associated antigen 3 (MAGE-3) protein, a member of the MAGE family known for its restricted expression in various tumor cells and limited presence in normal tissues. As a defined peptide sequence corresponding to amino acids 168 through 176 of the full MAGE-3 protein, it is widely utilized in immunological and cancer biology research. Its sequence specificity and immunogenic properties make it highly relevant for investigations into antigen presentation, T-cell epitope mapping, and the functional analysis of tumor-associated antigens in cellular and molecular studies.

Epitope Mapping: Researchers employ the MAGE-3 (168-176) peptide to delineate precise T-cell epitopes recognized by cytotoxic lymphocytes. By incorporating this fragment into in vitro assays, scientists can evaluate the specificity and magnitude of immune responses directed against MAGE-3-derived sequences. Such studies are integral to understanding how the immune system detects and targets tumor-associated antigens, facilitating the development of novel strategies for immunological intervention and antigen prioritization.

Antigen Presentation Studies: The peptide serves as a valuable reagent for probing the mechanisms of major histocompatibility complex (MHC) class I peptide loading and presentation. By pulsing antigen-presenting cells with MAGE-3 (168-176), investigators can monitor the efficiency of peptide processing, MHC binding affinity, and subsequent T-cell activation. These experiments provide critical insight into the molecular requirements for effective antigen display and recognition, informing both basic immunology and translational research efforts.

T-Cell Functional Assays: MAGE-3 (168-176) is frequently used in functional assays to characterize the activation, cytotoxicity, and cytokine secretion profiles of T lymphocytes specific to tumor-associated antigens. The peptide enables precise stimulation of T-cell clones or lines in vitro, allowing researchers to assess functional avidity, cross-reactivity, and the impact of immune modulation. Such data are essential for evaluating the immunogenicity of MAGE-3 epitopes and optimizing the design of experimental immunotherapies.

Peptide-Based Screening Platforms: The defined sequence and immunological relevance of MAGE-3 (168-176) make it suitable for use in high-throughput screening platforms aimed at identifying novel T-cell receptors or peptide-MHC binding partners. By incorporating the peptide into assay systems, scientists can efficiently screen for molecules or cells with desired specificity, accelerating the discovery of new immunological tools and potential research leads in the field of tumor antigen recognition.

Peptide Synthesis and Analytical Calibration: Beyond its functional applications, the MAGE-3 (168-176) peptide serves as a quality control standard in peptide synthesis and analytical workflows. Its defined sequence and physicochemical properties make it a reference material for validating chromatographic, mass spectrometric, or peptide purification protocols. This ensures reproducibility and accuracy in peptide-based research, supporting the reliable generation and characterization of related antigenic fragments or synthetic peptides for downstream applications.

1. Emu oil in combination with other active ingredients for treating skin imperfections

2. Myotropic activity of allatostatins in tenebrionid beetles

3. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

4. A possible role of tachykinin-related peptide on an immune system activity of mealworm beetle, Tenebrio molitor L

5. Cationic cell-penetrating peptides are potent furin inhibitors